Staphylococcal Skin and Soft Tissue Infections

Infect Dis Clin North Am. 2021 Mar;35(1):81-105. doi: 10.1016/j.idc.2020.10.003. Epub 2020 Dec 7.

Abstract

Staphylococcus aureus is the most common bacteria causing purulent skin and soft tissue infections. Many disease-causing S aureus strains are methicillin resistant; thus, empiric therapy should be given to cover methicillin-resistant S aureus. Bacterial wound cultures are important for characterizing local susceptibility patterns. Definitive antibiotic therapy is warranted, although there are no compelling data demonstrating superiority of any one antibiotic over another. Antibiotic choice is predicated by the infection severity, local susceptibility patterns, and drug-related safety, tolerability, and cost. Response to therapy is expected within the first days; 5 to 7 days of therapy is typically adequate to achieve cure.

Keywords: Acute bacterial skin and skin structure infections; Cellulitis with abscess; Purulent cellulitis; Staphylococcus aureus skin infection; Suppurative cellulitis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Abscess / microbiology
  • Abscess / therapy
  • Algorithms
  • Anti-Bacterial Agents / therapeutic use
  • Cellulitis / microbiology
  • Cellulitis / therapy
  • Drainage / methods
  • Humans
  • Impetigo / microbiology
  • Impetigo / therapy
  • Methicillin Resistance
  • Methicillin-Resistant Staphylococcus aureus / pathogenicity
  • Risk Factors
  • Soft Tissue Infections / diagnosis*
  • Soft Tissue Infections / microbiology
  • Soft Tissue Infections / therapy*
  • Staphylococcal Skin Infections / diagnosis*
  • Staphylococcal Skin Infections / microbiology
  • Staphylococcal Skin Infections / therapy*
  • Staphylococcus aureus / pathogenicity*

Substances

  • Anti-Bacterial Agents